S.N. Vyshelesski Institute of Experimental Veterinary

http://bievm.by/  
220063, Briketa ul., 28, Мinsk, Belarus Тel./fax: +375 17 517 32 61 E-mail: bievm@tut.by

Vaccine "Respivak" for the prevention of pasteurellosis in cattle caused by Pasteurella multocida serovariant A, B and Mannheimia haemolytica

COUNTRY OF ORIGIN

IDENTIFIER

BO8626

PUBLISHED

2023-12-08

LAST UPDATE

2023-12-13

DEADLINE

Linked profile in other language
Responsible
Alla Larkova
+375296298820
knir@tut.by
Summary
S.N. Vyshelesski Institute of Experimental Veterinary offers consumers an vaccine "Respivak" for the prevention of pasteurellosis in cattle caused by Pasteurella multocida serovariant A, B and Mannheimia haemolytica under a manufacturing agreement and is looking for partners interested in a distribution services agreement.
Description
PURPOSE:
The vaccine is used for vaccination of cattle for prophylactic purposes in farms that are unfavorable and threatened by pasteurellosis.

DESCRIPTION:
Homogeneous emulsion of grayish-white color. During storage, separation is allowed with the formation of a grayish sediment, which, when shaken, forms a uniform emulsion.

CHARACTERISTIC:
The vaccine contains bacteria Pasteurella multocida serovariants A, B and Mannheimia haemolytica, inactivated with formalin at a concentration of 0.4% and emulsified in an oil adjuvant. "Respivak" Causes the production of specific antibodies in cattle.

APPLICATION:
A homogeneous vaccine heated to a temperature of 37.0 ± 2.0 °C is administered intramuscularly once:
- vaccination of cows (heifers) is carried out regardless of the period of pregnancy in the fall (September-October) or spring (March-April) at a dose of 2.0 cubic cm. Heifers begin to be vaccinated at 15-16 months of age. Vaccination at other times is allowed according to the anti-epizootic action plan;
- vaccination of calves begins at 5-10 days of age at a dose of 1.0 cubic cm.;
- when equipping a farm with prefabricated livestock on days 2-5 or 10-12 days after delivery to the complex at a dose of 1.0 cubic cm. (depending on the current epizootic situation).

WAITING PERIOD:
The slaughter of animals for meat after the use of the vaccine is permitted without restrictions.

RELEASE FORM:
Sterile glass bottles of 10.0; 20.0; 50.0; 100.0; 200.0 or 400 cubic cm., sealed with rubber plugs and rolled metal caps.

STORAGE CONDITIONS:
The vaccine has a shelf life of 18 months from the date of manufacture, provided that it is stored and transported in a dry place, protected from light, at a temperature of plus 2 to plus 8 °C.

Download full instructions (in Russian). More details on the institute's website (in Russian).
Advantages and Innovations
Vaccines and drugs were developed and tested by the Institute’s staff, and also tested in accredited laboratories.
Stage of development
Already on the market
Funding source
State budged
Internal
IPR status
Exclusive rights
Secret know-how
Sector group
Agrofood
BioChemTech

Organization information

Type
R&D institution
Year established
1922
NACE keywords
A.01.61 - Support activities for crop production
M.72.11 - Research and experimental development on biotechnology
M.74.90 - Other professional, scientific and technical activities n.e.c.
Turnover (in EUR)
10-20M
Already engaged in transnational cooperation
Yes
Additional comments
The high level of development of animal husbandry in the Republic of Belarus is largely ensured by the efforts of veterinary medicine and its scientific and methodological center, which is the Republican Unitary Enterprise “S.N. Vyshelesski Institute of Experimental Veterinary".

Areas of activity of the Institute:
✔ development and improvement of methods for diagnosis, prevention, treatment, measures to combat infectious, parasitic and non-contagious diseases of farm animals, birds, bees;
✔ creation of modern vaccines, highly specific diagnostics, drugs, metabolic correction agents that provide veterinary protection of animals and obtain environmentally friendly livestock products;
✔ provision of scientific and practical assistance to the farms of the republic;
✔ training of highly qualified scientific personnel.

The tasks facing the Institute:
✔ conducting fundamental and applied research in the field of veterinary medicine in accordance with the main directions of economic and social development of the agro-industrial complex of the Republic of Belarus;
✔ conducting fundamental and applied research to study the mechanisms of immunity formation and the development of methods for its directed regulation;
✔ development of forecasts and programs for veterinary medicine;
✔ epizootological monitoring of the most common and parasitic infectious animal diseases, development of short-term and long-term forecasts of their occurrence and degree of manifestation;
✔ development of new and improvement of existing competitive means and methods for the diagnosis, prevention and treatment of infectious, parasitic and non-contagious animal diseases, the creation of integrated systems that ensure the protection of human health, the veterinary welfare of animal husbandry, obtaining environmentally friendly and high sanitary quality livestock products;
✔ isolation and study of the genetic, molecular and biological properties of pathogens of infectious diseases, selection and collection of useful strains that are promising for the creation of diagnosticums and vaccines;
✔ development of technologies for the production of veterinary drugs, vaccines, chemicals, antiparasitic agents.
Languages spoken
English
Russian

Information about partnership

Type of partnership considered
Distribution services agreement
Manufacturing agreement
Type and role of partner sought
Consumers interested in purchasing the Respivak vaccine for the prevention of pasteurellosis in cattle caused by Pasteurella multocida serovariant A, B and Mannheimia haemolytica under a manufacturing agreement.

Partners interested in purchasing the Respivak vaccine for the prevention of pasteurellosis in cattle caused by Pasteurella multocida serovariant A, B and Mannheimia haemolytica under a distribution services agreement.
Type and size of partner sought
> 500
251-500
SME 51-250
SME 11-50
SME <= 10
R&D Institution
University
Sole proprietor

Attachments

Views: 327
Statistics since 08.12.2023 12:20:01